Franklin

Fairness in Orphan Drug Exclusivity Act : report (to accompany H.R. 4712).

Author/Creator:
United States. Congress. House. Committee on Energy and Commerce, author.
Publication:
[Washington, D.C.] : [U.S. Government Publishing Office], [2020]
Format/Description:
Government document
Book
1 online resource (11 pages).
Series:
United States. Congress. House. Report ; 116-572.
Report / 116th Congress, 2d session, House of Representatives ; 116-572
Status/Location:
Loading...

Options
Location Notes Your Loan Policy

Details

Subjects:
United States. Food and Drug Administration.
Drug development -- Economic aspects -- United States.
Buprenorphine -- Therapeutic use -- United States.
Orphan drugs -- Government policy -- United States.
Drugs -- Prices -- Government policy -- United States.
Drugs -- Law and legislation -- United States.
Orphan drugs -- United States.
Rare diseases -- United States.
Form/Genre:
Legislative materials.
Notes:
"November 16, 2020."
GPO Cataloging Record Distribution Program (CRDP).
Includes bibliographical references.
Description based on online resource; title from PDF caption (govinfo, viewed Nov. 30, 2020).
Other format:
Print version: United States. Congress. House. Committee on Energy and Commerce. Fairness in Orphan Drug Exclusivity Act
OCLC:
1224541481